Further studies aimed at exploring the potential mechanisms that could help rare progenitor-like breast cancer cells survive metabolic challenges, indicated the involvement of several regulators of energy balance such as ARID5B, IRX5, and CUX1 P200 repressor besides FTO and IRX3. Here, FTO is linked to breast cancer.